Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126828571 | 12682857 | 1 | I | 20160801 | 20160825 | 20160825 | PER | US-ASTRAZENECA-2016SE83783 | ASTRAZENECA | 44.00 | YR | F | Y | 0.00000 | 20160825 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126828571 | 12682857 | 1 | PS | PRILOSEC OTC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21229 | MODIFIED-RELEASE TABLET | ||||||||
126828571 | 12682857 | 2 | SS | CHANTIX | VARENICLINE TARTRATE | 1 | Unknown | U | 0 | ||||||||||
126828571 | 12682857 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
126828571 | 12682857 | 4 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
126828571 | 12682857 | 5 | C | ANTACID | ALUMINUM HYDROXIDECALCIUM CARBONATEDIMETHICONEMAGNESIUM HYDROXIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126828571 | 12682857 | 1 | Antacid therapy |
126828571 | 12682857 | 2 | Tobacco withdrawal symptoms |
126828571 | 12682857 | 3 | Blood pressure abnormal |
126828571 | 12682857 | 4 | Blood pressure abnormal |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126828571 | 12682857 | Drug ineffective | |
126828571 | 12682857 | Enuresis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |